PMID- 17805954
OWN - NLM
STAT- MEDLINE
DCOM- 20080205
LR  - 20220331
IS  - 0920-3206 (Print)
IS  - 0920-3206 (Linking)
VI  - 21
IP  - 5
DP  - 2007 Oct
TI  - Determinants of costs and the length of stay in acute coronary syndromes: a real 
      life analysis of more than 10,000 patients.
PG  - 389-98
AB  - AIMS: The aim of this study was to investigate inpatient costs of acute coronary 
      syndromes (ACS) in Switzerland and to assess the main cost drivers associated 
      with this disease. METHODS AND RESULTS: We used the national multicenter registry 
      AMIS (acute myocardial infarction in Switzerland) which includes a representative 
      number of 65 hospitals and a total of 11.623 patient records. The following cost 
      modules were analyzed: hospital stay, percutaneous coronary interventions (PCI) 
      and thrombolysis. Expenses were assessed using data from official Swiss national 
      statistical sources. Mean total costs per patient were 12.101 Euro (median 10.929 
      Euro; 95% CI: 1.161-27.722 Euro). The length of stay ranged from one to 129 days 
      with a mean of 9.5 days (median 8.0 days; 95% CI: 1-23). Overall costs were 
      independently influenced by age, gender and existent co-morbidities, e.g. 
      cerebrovascular disease and diabetes (p < 0.0001). CONCLUSION: Our study 
      determined specific causes for the high costs associated with hospital treatment 
      on a large representative sample. The results should highlight unnecessary 
      expenses and help policy makers to evaluate the base case for a DRG (Diagnosis 
      Related Groups) scenario in Switzerland. Cost weighting of the identified 
      secondary diagnosis should be considered in the calculation and coding of a 
      primary diagnosis for ACS.
FAU - Bramkamp, Matthias
AU  - Bramkamp M
AD  - Department of Internal Medicine, University Hospital of Zurich, RAE B 40, 
      Ramistr. 100, CH-8091 Zurich, Switzerland. Matthias.Bramkamp@usz.ch
FAU - Radovanovic, Dragana
AU  - Radovanovic D
FAU - Erne, Paul
AU  - Erne P
FAU - Szucs, Thomas D
AU  - Szucs TD
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Cardiovasc Drugs Ther
JT  - Cardiovascular drugs and therapy
JID - 8712220
SB  - IM
MH  - Acute Coronary Syndrome/diagnosis/*economics/therapy
MH  - Aged
MH  - Angioplasty, Balloon, Coronary/*economics/statistics & numerical data
MH  - Comorbidity
MH  - Databases, Factual/statistics & numerical data
MH  - Female
MH  - Hospital Costs/*statistics & numerical data
MH  - Humans
MH  - Length of Stay/*economics/statistics & numerical data
MH  - Male
MH  - Middle Aged
MH  - Multivariate Analysis
MH  - *Outcome Assessment, Health Care
MH  - *Registries
MH  - Risk Factors
MH  - Switzerland
MH  - Thrombolytic Therapy/*economics/statistics & numerical data
EDAT- 2007/09/07 09:00
MHDA- 2008/02/06 09:00
CRDT- 2007/09/07 09:00
PHST- 2007/09/07 09:00 [pubmed]
PHST- 2008/02/06 09:00 [medline]
PHST- 2007/09/07 09:00 [entrez]
AID - 10.1007/s10557-007-6044-0 [doi]
PST - ppublish
SO  - Cardiovasc Drugs Ther. 2007 Oct;21(5):389-98. doi: 10.1007/s10557-007-6044-0.